Intranasal drug delivery systems offer a non-invasive approach to transporting therapeutic agents directly to the central nervous system by circumventing the blood–brain barrier. These systems exploit ...

The European Medicines Agency (EMA) on Tuesday published an analysis highlighting the complexity of developing treatments for central nervous system (CNS) disorders, such as Alzheimer's disease, ...

In Q1 2026, Praxis Precision Medicines reported that the FDA accepted New Drug Applications for ulixacaltamide in essential tremor and relutrigine in developmental and epileptic encephalopathies, with ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Actionable insights into research ...

Summary: A milestone neuro-regenerative study has shattered a long-standing medical dogma by proving that “irreversible” damage to the connections between the human brain and spinal cord can be ...

Sanofi has tapped Alloy Therapeutics to enable development of a central nervous system drug, agreeing to pay $27.5 million in upfront and near-term fees to access an antisense platform. Alloy is ...

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, ...

Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...